A new study led by Dartmouth announced this month New England Journal of Medicine It highlights the role of the US healthcare system in receiving racial inequality in receiving prescription analgesics.
For over a decade, studies have shown that black patients in the United States do not suffer from so much prescription pain. medicine So Caucasian patient.. However, the causes of these differences are not well understood.
To this end, researchers examined racial differences in receiving prescription analgesics between patients in 310 health systems that offer: Primary care service To a significant number of both black and white patients.
They found that while black and white patients were equally likely to receive prescription analgesics, the doses were significantly different. In 90% of the systems surveyed, white patients received higher annual doses on average than black patients (the difference was more than 15% in most systems).
Past research on others Medical services Black and white patients (such as heart surgery) often receive care from different health systems and have been proven to receive different qualities or intensities of care (black patients have a lower quality care system). Often serviced by).
This new study reveals that such “classifications” are different Medical system Little explanation (if doctors may have different prescribing practices) Race difference With a receipt for prescription painkillers. Instead, even when treated by the same medical system and team of clinicians, the difference is due to black and white patients receiving almost completely different analgesic doses.
“Our findings may reflect systematic racial prejudice throughout the care process leading to the receipt of analgesics,” said Dartmouth College Research Consultant and Dartmouth Hitchcock Health. And Nancy Morden, MD, a former physician researcher at Dartmouth College of Medicine, explains. In Dartmouth, the lead author of the study. “We hope that our system-level reporting will facilitate dialogue and commitment to this deep quest for inequality. It is the cause, consequences, and tireless testing of potential remedies.”
Interpreting their findings, the authors authorize whether or how these differences affect patient outcomes, as both underuse and overuse of opioids can cause harm. Make it clear that you can’t know. However, they emphasize that skin color should not affect the treatment of pain.
“The 10-year national data on racial inequality in receiving prescription opioids is in receiving analgesics because no individual or group is tasked with receiving analgesics or alleviating national medical inequality. It rarely narrowed the known racial gap, “said Dr. Ellen Meara, senior author and part-time professor at Geisel’s Dartmas Health Policy and Clinical Practice Institute.
“In contrast, healthcare leaders regularly hold healthcare providers and organizations accountable for the care they provide to their patients, and leaders have voiced their commitment to fairness. I need the data to do that. “
Researchers hope that system-level reporting of racial differences in the receipt of analgesics encourages physicians and managers to develop efforts aimed at pondering and ensuring the causes of these differences. I’m out. Skin color Does not affect pain management.
Dartmouth College of Medicine
Quote: According to the survey, the US medical system obtained on July 21, 2021 from https: //medicalxpress.com/news/2021-07-explores-inequity-opioid-health.html (July 21, 2021) Investigating racial inequality in opioid prescriptions in
This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. The content is provided for informational purposes only.
Study explores race inequity in opioid prescribing among US health systems Source link Study explores race inequity in opioid prescribing among US health systems